Peter Revill

occupation: researcher

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 54

Date

Title

Authors

2022-07-20

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

Kyong-Mi Chang, Dieter Glebe, Capucine Pénicaud, Teresa Pollicino, Barbara Testoni, Adam J Gehring, Mala K Maini, Ulrike Protzer, Fabien Zoulim, Peter Revill, Maura Dandri, Ourania M Andrisani, Gavin Cloherty, Anna Kramvis
2019-04-01

Meeting the Challenge of Eliminating Chronic Hepatitis B Infection

Peter Revill, Fabien Zoulim
2019-04-10

A global scientific strategy to cure hepatitis B

Peter Revill, Massimo Levrero, Swee Kee Wong, Fabien Zoulim, Mala K Maini, Anna Kramvis
2018-01-24

A research agenda for curing chronic hepatitis B virus infection

Robert Gish, Jordan J Feld, Swee Kee Wong, Anand Mehta, Peter Revill, Fabien Zoulim, Harvey J. Alter, Charles M. Rice, Kris V. Kowdley
2018-02-22

Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype

Peter Revill, Kathrin Gibbert
2018-02-10

ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B.

Darren Wong, Margaret Littlejohn, Peter Revill, Patrick Marcellin
2018-05-04

In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease

Peter Revill, Danni Colledge, Stephen Locarnini
2018-09-27

Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood

Anna L McNaughton, M Azim Ansari, Sheila Lumley, Margaret Littlejohn, Peter Revill, Jane A. McKeating, Philippa C Matthews, Valentina D'Arienzo
2018-06-22

Molecular characterization of hepatitis B virus (HBV) in African children living in Australia identifies genotypes and variants associated with poor clinical outcome

Margaret Littlejohn, Peter Revill, Danni Colledge, Stephen Locarnini
2017-04-07

Taxonomy of the order Mononegavirales: update 2017.

Peter Walker, Gaya K. Amarasinghe, Yiming Bào, Christopher F Basler, Sina Bavari, Nicolas Bejerman, Kim R Blasdell, Alisa Bochnowski, Thomas Briese, Alexander Bukreyev, Kartik Chandran, Ralf Dietzgen, Olga Dolnik, John M Dye, Andrew J Easton, Hideki Ebihara, Pierre Formenty, Ron Fouchier, Elodie Ghedin, Robert M. Harding, Roger Hewson, Masayuki Horie, Anthony P. James, Gary P. Kobinger, Gael Kurath, Benhur Lee, Andrea Maisner, Elke Mühlberger, Sergey Netesov, Norbert Nowotny, Susan L Payne, Janusz Pawęska, Richard E Randall, Peter Revill, David M Stone, Calogero Terregino, Nikos Vasilakis, Viktor Volchkov, Victoria Wahl-Jensen, Anna E Whitfield, Zhichao Yan, Gōngyín Yè, Jens H. Kuhn, Charles H. Calisher, Noël Tordo, Robert B. Tesh, Paul A. Rota, Bertus K Rima, Jonathan S Towner, Eric M Leroy, Ayato Takada, Daohong Jiang, Hideki Kondō, Dennis Rubbenstroth, Keizo Tomonaga, John Werren, Qi Fang
2017-09-08

Hepatitis B amongst Immigrants from Myanmar: Genotypes and their Clinical Relevance

Thomas R Schulz, Lilly Yuen, Margaret Littlejohn, Peter Revill, Beverley-Ann Biggs
2017-10-11

HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patients

Darren Wong, Margaret Littlejohn, Peter Revill
2016-04-01

Overview of hepatitis B viral replication and genetic variability

Peter Revill
2016-02-22

New perspectives on the hepatitis B virus life cycle in the human liver

Peter Revill
2016-08-10

In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes

Margaret Littlejohn, Nadia Warner, Lilly Yuen, Peter Revill, Danni Colledge, Stephen Locarnini
2016-10-01

Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA)

Peter Revill
2016-07-27

Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation

Brigid D Betz-Stablein, Margaret Littlejohn, Peter Revill, Nadia Warner
2016-12-09

Genotypic profiles of hepatitis B in African immigrants and their clinical relevance

Thomas R Schulz, Margaret Littlejohn, Peter Revill, Beverley-Ann Biggs
2016-11-14

Ethics and hepatitis B cure research

Sharon R. Lewin, Jeremy Sugarman, Peter Revill, Fabien Zoulim, Yazdan Yazdanpanah
2016-08-17

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.

Julianne Bayliss, Lilly Yuen, Margaret Littlejohn, Peter Revill, Patrick Marcellin, Maria Buti, Danni Colledge, Stephen Locarnini
2016-10-01

Erratum to: Complete genome sequence of Colocasia bobone disease-associated virus, a putative cytorhabdovirus infecting taro

Nicolas Bejerman, Peter Revill, Robert M. Harding, Ralf Dietzgen
2016-11-24

Reply: 'More viral mutants, less HBsAg clearance? One size may not fit all'

Peter Revill
2016-02-24

Global strategies are required to cure and eliminate HBV infection

Barbara Testoni, Peter Revill, Fabien Zoulim
2015-04-20

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus

Gregor Ebert, Simon Preston, Michael D Stutz, Ueli Nachbur, Joseph Torresi, Nadia Warner, Peter Revill, John Silke, Marc Pellegrini
2015-10-05

Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients

Kumar Visvanathan, Ashley Mansell, Tali Lang, Kathleen Ryan, Sang Hoon Ahn, Peter Revill
2015-12-21

Complete genome sequence of Colocasia bobone disease-associated virus, a putative cytorhabdovirus infecting taro

Nicolas Bejerman, Anthony P. James, Peter Revill, Robert M. Harding, Ralf Dietzgen
2014-04-01

Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patients

Rino Gani, Peter Revill, Irsan Hasan, Laurentius A Lesmana, Seng Gee Lim
2014-05-28

Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen

Robert De Rose, Julianne Bayliss, Kumar Visvanathan, Stephen J. Kent, Peter Revill
2014-06-11

Viral factors and predicting disease outcomes in chronic hepatitis B.

Peter Revill
2013-01-11

Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus

Margaret Littlejohn, Peter Revill, Sharon R. Lewin, Jennifer Hoy, Kiat Ruxrungtham, Chloe L Thio, Eric C Seaberg, Gregory J Dore
2013-05-01

Advances in the molecular diagnosis of hepatitis B infection: providing insight into the next generation of disease

Julianne Bayliss, Peter Revill
2012-08-01

In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection

Sharon R. Lewin, Margaret Littlejohn, Peter Revill, Chloe L Thio, Danni Colledge, Stephen Locarnini

Human - wd:Q40445953

Welcome to Inventaire

the library of your friends and communities

learn more